Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No discussion of the 890?

Opty, Anyone,

I am of the belief that TPL is actively pursuing and negotiating with companies to license the MMP even though there have been no news of any signings. And thus my question, (and please forgive if this is dumb).

Can TPL lisense the MMP to companies and delay reporting them in news releases? Or are they(TPL/PTSC) obligated by SEC rules or Master Agreement to report all licensing at the time of signing?

Sorry if this is dumb or has been answered already. TIA.

Regards,
PxP

Share
New Message
Please login to post a reply